Keurig Dr Pepper Inc. filed an 8-K on November 16, 2026, disclosing the completion of a common stock offering that raised approximately $2.25 billion in net proceeds, with the underwriters exercising their overallotment option in full.
Key Highlights
- Base offering size: 57,971,015 shares of common stock at a public offering price of $34.50 per share.
- Overallotment exercised in full: Underwriters purchased an additional 8,695,652 shares, bringing the total to 66,666,667 shares.
- Net proceeds: Approximately $2.25 billion, after deducting the underwriting discount but before other offering fees and expenses.
- Underwriters: Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC.
- Proceeds use: The company intends to repay or repurchase outstanding debt, which may include its Delayed Draw Term Loan Agreement, commercial paper notes, and senior unsecured notes.
- Offering completed: November 16, 2026, pursuant to a registration statement on Form S-3ASR (File No. 333-289652).
Keurig Dr Pepper Completes $2.25 Billion Common Stock Offering to Reduce Debt
According to the filing, Keurig Dr Pepper Inc. (NASDAQ:KDP) entered into an underwriting agreement on November 12, 2026, with Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC. Under that agreement, the company agreed to sell 57,971,015 shares of its common stock, par value $0.01 per share, at a public offering price of $34.50 per share. The company also granted the underwriters an option to purchase up to an additional 8,695,652 shares.
The filing disclosed that the offering was completed on November 16, 2026, with the underwriters exercising their option in full. As a result, a total of 66,666,667 shares were sold. The company reported receiving approximately $2.25 billion of net proceeds after deducting the underwriting discount, though the filing noted this figure does not reflect other offering fees and expenses yet to be deducted.
The company disclosed that it intends to use the net proceeds to repay or repurchase outstanding debt. The filing identified potential uses as including "borrowings under its Delayed Draw Term Loan Agreement, commercial paper notes and senior unsecured notes." The offering was conducted under the company's registration statement on Form S-3ASR (File No. 333-289652), supplemented by a preliminary prospectus supplement filed November 12, 2026, and a final prospectus supplement dated November 12, 2026, and filed with the SEC on November 13, 2026. The filing was signed by Anthony Shoemaker, Chief Legal Officer, General Counsel and Secretary.
What Was Disclosed
Keurig Dr Pepper disclosed the terms, completion, and proceeds of a common stock offering totaling approximately 66.7 million shares at $34.50 each, raising roughly $2.25 billion in net proceeds intended for debt repayment or repurchase.




Please wait processing your request...